KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Depreciation & Amortization (CF): 2020-2025

Historic Depreciation & Amortization (CF) for Hims & Hers Health (HIMS) over the last 6 years, with Sep 2025 value amounting to $17.7 million.

  • Hims & Hers Health's Depreciation & Amortization (CF) rose 303.13% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.5 million, marking a year-over-year increase of 210.35%. This contributed to the annual value of $17.1 million for FY2024, which is 79.59% up from last year.
  • Hims & Hers Health's Depreciation & Amortization (CF) amounted to $17.7 million in Q3 2025, which was up 68.84% from $10.5 million recorded in Q2 2025.
  • Hims & Hers Health's Depreciation & Amortization (CF)'s 5-year high stood at $17.7 million during Q3 2025, with a 5-year trough of $394,000 in Q1 2021.
  • Its 3-year average for Depreciation & Amortization (CF) is $5.7 million, with a median of $3.6 million in 2024.
  • Data for Hims & Hers Health's Depreciation & Amortization (CF) shows a peak YoY spiked of 415.33% (in 2021) over the last 5 years.
  • Over the past 5 years, Hims & Hers Health's Depreciation & Amortization (CF) (Quarterly) stood at $1.6 million in 2021, then rose by 23.31% to $2.0 million in 2022, then spiked by 32.24% to $2.7 million in 2023, then spiked by 128.03% to $6.1 million in 2024, then surged by 303.13% to $17.7 million in 2025.
  • Its last three reported values are $17.7 million in Q3 2025, $10.5 million for Q2 2025, and $8.3 million during Q1 2025.